EIGER BIOPHARMACEUTICALS, INC. (NASDAQ: EIGR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR)
09 nov. 2022 14h00 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Eiger BioPharmaceuticals, Inc.? If so, please visit Eiger BioPharmaceuticals, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
Eiger BioPharmaceuticals Shareholder News: Johnson Fistel Encourages EIGR Shareholders with Losses to Contact the Firm Regarding Investigation
09 sept. 2022 17h42 HE
|
Johnson Fistel, LLP
SAN DIEGO, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), any of...